Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg)
Clinical trial NCT00983996 · COMPLETED
Trial details
- NCT number
- NCT00983996
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2002-07-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.